Peripheral T cell lymphoma: clinical utility of romidepsin

Jasmine Zain, Kathryn SaweyNYU Langone Medical Center, New York, USAIntroduction: Direct therapeutic targets, such as aberrant tumor cell genes and tumor cell markers, have been the focus of cancer treatment for more than 50 years. The resulting damage to normal cells and emergence of drug-resistant...

Full description

Bibliographic Details
Main Authors: Sawey K, Zain J
Format: Article
Language:English
Published: Dove Medical Press 2012-06-01
Series:Blood and Lymphatic Cancer : Targets and Therapy
Online Access:http://www.dovepress.com/peripheral-t-cell-lymphoma-clinical-utility-of-romidepsin-a10099

Similar Items